The present study has been proposed to investigate the long-term safety and efficacy of EnXtra in healthy adults habituated to caffeine.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Enrollment
60
2 capsules
2 capsules
2 capsules
Vedic Lifesciences Pvt. Ltd
Mumbai, Opp Infinity Mall, India
Change in ECG from baseline to end of the treatment.
ECG parameters including PR interval, QRS duration, QT interval and RR interval will be evaluated from baseline and end of the treatment
Time frame: 84 Days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.